Works matching Drug prices

Results: 5000

Analysis of e-catalogue drug prices in the era of Universal Health Coverage in the Indonesian pharmaceutical industry.

Published in:

Pharmacia (0428-0296), 2022, v. 69, n. 2, p. 555, doi. 10.3897/pharmacia.69.e83068

By:

Satibi, Satibi;
P., Luthfi Kinanthi Kirana;
P., Mella Aziza;
Hutasoit, Monica;
Pribadi, Prasojo

Publication type:

Article

ID 169. The Impact of Rising Drug Prices in Egypt.

Published in:

Journal of Pharmacy & Bioallied Sciences, 2020, v. 12, p. 909

By:

Abdeldaiem, Mahmoud Said Ibrahim;
Fathalla, Nour Allah Hassan;
El-Sayed, Nouran Ehab Hassan;
Hedaya, Heidy Yasser

Publication type:

Article

Generic entry and effect of market competition on outpatient pharmacy drug prices.

Published in:

Journal of Generic Medicines, 2024, v. 20, n. 2, p. 69, doi. 10.1177/17411343241248521

By:

Jamjoom, Mohammed;
Almutairi, Reem D;
Seoane-Vazquez, Enrique;
Brown, Lawrence M;
Burnham, Terence;
Rakovski, Cyril;
Rodriguez-Monguio, Rosa

Publication type:

Article

The Price Effect of Drug Price Ceilings: Intended and Unintended Consequences.

Published in:

Management Science, 2022, v. 68, n. 8, p. 5758, doi. 10.1287/mnsc.2021.4166

By:

Li, Jun;
Wu, Di

Publication type:

Article

Impact of Regulatory Policy Changes on Generic Drug Prices in the United States.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2023, v. 57, n. 2, p. 617, doi. 10.5530/ijper.57.2.76

By:

Singh, Rajender;
Singh, Swati;
Kumar, Anil;
Kulkarni, G. T.;
Thakkar, Arti R.

Publication type:

Article

Variables affecting new drug prices in South Korea's pricing system.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1370915

By:

Dong Yun Lee;
Seong Ha Cho;
Da Hye Lee;
Su Jeong Kang;
Jong Hyuk Lee

Publication type:

Article

Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model.

Published in:

Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1179253

By:

Narendrula, Aparna;
Lang, Jacob;
Mossialos, Elias

Publication type:

Article

Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis.

Published in:

2021

By:

Wang, Ni;
Yang, Ying;
Xu, Luxinyi;
Mao, Zongfu;
Cui, Dan

Publication type:

journal article

基于主要信息含量药品价格特征指标体系的构建.

Published in:

Journal of Pharmaceutical Practice & Service, 2018, v. 36, n. 5, p. 422, doi. 10.3969/j.issn.1006-0111.2018.05.008

By:

李建;
舒丽芯

Publication type:

Article

Can Drug Price Controls Help Patients Get a Better Deal? A SWOT Analysis.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2023, v. 19, n. 6, p. 222, doi. 10.47836/mjmhs.19.6.30

By:

Wahab, Siti Norida;
Sahak, Muhammad Yazid

Publication type:

Article

Why Lower Drug Prices Benefit Institutional Investors: an application of universal ownership theory.

Published in:

Corporate Governance: An International Review, 2007, v. 15, n. 3, p. 455, doi. 10.1111/j.1467-8683.2007.00578.x

By:

Lippman, Steve;
Rosan, Daniel E.;
Seitchik, Adam

Publication type:

Article

The effects of dynamic and static competition on prescription drug prices in Denmark, 1997–2017.

Published in:

Journal of Evolutionary Economics, 2022, v. 32, n. 4, p. 1155, doi. 10.1007/s00191-022-00777-4

By:

Lichtenberg, Frank R.

Publication type:

Article

Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada.

Published in:

ClinicoEconomics & Outcomes Research, 2024, v. 16, p. 437, doi. 10.2147/CEOR.S462872

By:

Rawson, Nigel SB;
Stewart, David J

Publication type:

Article

Research on the sharing mechanism of drug price information in China-from the perspective of intergovernmental information sharing.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2018, v. 27, n. 8, p. 582, doi. 10.5246/jcps.2018.08.059

By:

Shuai Wang;
Ting Yin;
Ningtai Luo;
Xiaoping Liu;
Bin Jiang

Publication type:

Article

Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China.

Published in:

2015

By:

Junyong Wang;
Xia Liu;
Suzhen Wang;
Heli Chen;
Xun Wang;
Wei Zhou;
Li Wang;
Yanchen Zhu;
Xianping Zheng;
Mo Hao

Publication type:

Case Study

Is greater generic competition also linked to lower drug prices in South Korea?

Published in:

Health Economics Review, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13561-020-00289-6

By:

Son, Kyung-Bok

Publication type:

Article

Drugs Prices and Systemic Violence: An Empirical Study.

Published in:

European Journal on Criminal Policy & Research, 2008, v. 14, n. 4, p. 391, doi. 10.1007/s10610-008-9080-9

By:

Sarrica, Fabrizio

Publication type:

Article

The impact of patent expiry on drug prices: insights from the Dutch market.

Published in:

Journal of Market Access & Health Policy, 2021, v. 9, n. 1, p. 1, doi. 10.1080/20016689.2020.1849984

By:

van der Schans, Simon;
Vondeling, Gert T.;
Cao, Qi;
van der Pol, Simon;
Visser, Sipke;
Postma, Maarten J.;
Rozenbaum, Mark H.

Publication type:

Article

Why "American Patients First" is likely to raise drug prices outside of the United States.

Published in:

Journal of Market Access & Health Policy, 2019, v. 7, n. 1, p. 1, doi. 10.1080/20016689.2019.1650596

By:

Dabbous, Monique;
Milea, Cyprien;
Simoens, Steven;
François, Clement;
Dussart, Claude;
Chachoua, Lylia;
Borissov, Borislav;
Toumi, Mondher

Publication type:

Article

President Trump's prescription to reduce drug prices: from the campaign trail to American Patients First.

Published in:

Journal of Market Access & Health Policy, 2019, v. 7, n. 1, p. 1, doi. 10.1080/20016689.2019.1579597

By:

Dabbous, Monique;
François, Clément;
Chachoua, Lylia;
Toumi, Mondher

Publication type:

Article

The impact of early phase price agreements on prices of orphan drugs.

Published in:

2021

By:

Nuijten, Mark;
Van Wilder, Philippe

Publication type:

journal article

Impact of drug price regulation on patient access to medicines: A systematic review.

Published in:

Matrix Science Pharma, 2023, v. 7, n. 4, p. 112, doi. 10.4103/mtsp.mtsp_23_23

By:

Ashiwaju, Bankole;
Orikpete, Ochuko;
Alade, Elesho;
Raji, Ahmed;
Adesanya, Abel;
Nwankwo, Tochukwu

Publication type:

Article

Correlation of Anticancer Drug Prices with Outcomes of Overall Survival and Progression-Free Survival in Clinical Trials in Japan.

Published in:

Current Oncology, 2023, v. 30, n. 2, p. 1776, doi. 10.3390/curroncol30020137

By:

Okabe, Ayano;
Hayashi, Haruto;
Maeda, Hideki

Publication type:

Article

Does drug price-regulation affect healthcare expenditures?

Published in:

2017

By:

Ben-Aharon, Omer;
Shavit, Oren;
Magnezi, Racheli

Publication type:

journal article

The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data.

Published in:

BMC Public Health, 2024, v. 24, p. 1, doi. 10.1186/s12889-024-18820-3

By:

Li, Bao-Xin;
Wang, Ya-Qun;
Yi, Yuan-Yuan;
Zhou, Na;
Lv, Zi-Xuan;
Ma, Rui;
Li, Xin;
Yuan, Ni

Publication type:

Article

Monitoramento de políticas públicas em direitos fundamentais: a regulação de preços de medicamentos por meio da CMED.

Published in:

Revista Brasileira de Políticas Públicas, 2024, v. 14, n. 2, p. 228, doi. 10.5102/rbpp.v14i2.8874

By:

Villa Verde, Rômulo Goretti;
de Oliveira Rodrigues, Liziene;
Chein Feres, Marcos Vinicio

Publication type:

Article

Drug Prices - How Much is too Much?

Published in:

Journal of Intellectual Property Rights, 2012, v. 17, n. 5, p. 497

By:

Nair, Manu S.

Publication type:

Article

New Evidence of the Impact of the National Drug Price Negotiation Policy on the Availability, Utilization, and Cost of Anticancer Medicines in China: An Interrupted Time Series Study.

Published in:

Risk Management & Healthcare Policy, 2024, v. 17, p. 2201, doi. 10.2147/RMHP.S473846

By:

Gao, Xingyuan;
Yu, Man;
Sun, Yuyang;
Zhang, Tiansi;
Li, Xin;
Zhang, Lingli;
Wang, Changqing

Publication type:

Article

WILL PRESCRIPTION DRUG PRICES EVER STOP RISING? A WORK AROUND TO AVOIDING THE DORMANT COMMERCE CLAUSE IN STATE REGULATION OF DRUG PRICES.

Published in:

University of Pennsylvania Journal of Constitutional Law, 2024, v. 26, n. 6, p. 1667, doi. 10.58112/jcl.26-6.6

By:

Nwakama, Chisom

Publication type:

Article

Price of drugs for chronic myeloid leukemia (CML), reflection of the unsustainable cancer drug prices: perspective of CML Experts.

Published in:

Current Medical Literature: Leukemia & Lymphoma, 2013, v. 21, n. 2, p. 64

By:

Mead, Adam

Publication type:

Article

Gang wars, gang employment and drug prices.

Published in:

Journal of Bioeconomics, 2019, v. 21, n. 1, p. 37, doi. 10.1007/s10818-018-09281-x

By:

Prinz, Aloys;
Ehrmann, Thomas

Publication type:

Article

Analysis of the evolution of the price of oncology drugs after the loss of their patent and the marketing of generic medicines.

Published in:

Global & Regional Health Technology Assessment, 2022, v. 9, n. 1, p. 68, doi. 10.33393/grhta.2022.2366

By:

Martínez-Sesmero, José M.;
Smith, Borja;
Madurga, Julen

Publication type:

Article

Changes in Price for Generic Drugs in the USA, 2008-2016.

Published in:

2019

By:

Dave, Chintan V.;
Brill, Gregory;
Kesselheim, Aaron S.

Publication type:

Letter

Medicare-approved drug discount cards and prescription drug prices.

Published in:

American Journal of Health-System Pharmacy, 2005, v. 62, n. 14, p. 1482, doi. 10.2146/ajhp050012

By:

Chisholm, Marie A.;
Turner, Jeanie Chinaye;
Dipiro, Joseph T.

Publication type:

Article

Price negotiation and pricing of anticancer drugs in China: An observational study.

Published in:

PLoS Medicine, 2024, v. 21, n. 1, p. 1, doi. 10.1371/journal.pmed.1004332

By:

Zhou, Jing;
Lan, Tianjiao;
Lu, Hao;
Pan, Jay

Publication type:

Article

Off-patent drugs at brand-name prices: a puzzle for policymakers.

Published in:

Journal of Law & the Biosciences, 2016, v. 3, n. 1, p. 238, doi. 10.1093/jlb/lsw008

By:

Tallapragada, Naren P.

Publication type:

Article

Legislating Drug Price Transparency.

Published in:

Regulation, 2017, v. 40, n. 2, p. 4

By:

HEMPHILL, THOMAS A.

Publication type:

Article

Changes in Drug List Prices and Amounts Paid by Patients and Insurers.

Published in:

Journal of Managed Care Nursing, 2021, v. 7, n. 4, p. 4

By:

Yang, Eric J.;
Galan, Emilio;
Thombley, Robert;
Lin, Andrew;
Seo, Jaeyun;
Chien-Wen Tseng;
Resneck, Jack S.;
Bach, Peter B.;
Dudley, R. Adams

Publication type:

Article

Expensive seems better: The price of a non-effective drug modulates its perceived efficacy.

Published in:

Cognitive Research: Principles & Implications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41235-023-00463-4

By:

Díaz-Lago, Marcos;
Blanco, Fernando;
Matute, Helena

Publication type:

Article

Clinical benefit, development, innovation, trials, epidemiology, and price for cancer drugs and indications with multiple special FDA designations.

Published in:

JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 216, doi. 10.1093/jnci/djad212

By:

Michaeli, Daniel Tobias;
Michaeli, Thomas;
Albers, Sebastian;
Michaeli, Julia Caroline

Publication type:

Article

Industrial effects of latest China's medical reform on drug prices.

Published in:

Peking University Law Journal, 2021, v. 9, n. 2, p. 213, doi. 10.1080/20517483.2021.2020499

By:

Yang, Ming

Publication type:

Article

Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis.

Published in:

PharmacoEconomics, 2011, v. 29, n. 1, p. 1, doi. 10.2165/11584230-000000000-00000

By:

Hoyle, Martin

Publication type:

Article

Future Drug Prices and Cost-Effectiveness Analyses.

Published in:

PharmacoEconomics, 2008, v. 26, n. 7, p. 589, doi. 10.2165/00019053-200826070-00006

By:

Hoyle, Martin

Publication type:

Article

Predicting the next round of drugs for Medicare price negotiation.

Published in:

Science Translational Medicine, 2024, v. 16, n. 776, p. 1, doi. 10.1126/scitranslmed.adq5711

By:

Vogel, Matthew;
Tellier, Adam;
Conti, Rena M.

Publication type:

Article

Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.

Published in:

Addiction, 2017, v. 112, n. 4, p. 640, doi. 10.1111/add.13720

By:

Gouwe, Daan;
Brunt, Tibor M.;
Laar, Margriet;
Pol, Peggy

Publication type:

Article

Competition and price among brand-name drugs in the same class: A systematic review of the evidence.

Published in:

2019

By:

Sarpatwari, Ameet;
DiBello, Jonathan;
Zakarian, Marie;
Najafzadeh, Mehdi;
Kesselheim, Aaron S.

Publication type:

journal article

STATE AND FEDERAL POLICY SOLUTIONS TO RISING PRESCRIPTION DRUG PRICES IN THE U.S.

Published in:

Journal of Health Care Law & Policy, 2019, v. 22, n. 2, p. 15

By:

PADULA, WILLIAM V.

Publication type:

Article

DOES MEDICARE REIMBURSEMENT DRIVE UP DRUG LAUNCH PRICES?

Published in:

Review of Economics & Statistics, 2020, v. 102, n. 5, p. 980, doi. 10.1162/rest_a_00849

By:

Ridley, David B.;
Chung-Ying Lee

Publication type:

Article

Variation in Prescription Drug Prices by Retail Pharmacy Type: A National Cross-sectional Study.

Published in:

2019

By:

Luo, Jing;
Kulldorff, Martin;
Sarpatwari, Ameet;
Pawar, Ajinkya;
Kesselheim, Aaron S.

Publication type:

journal article

High Generic Drug Prices and Market Competition: A Retrospective Cohort Study.

Published in:

2017

By:

Dave, Chintan V.;
Kesselheim, Aaron S.;
Fox, Erin R.;
Qiu, Peihua;
Hartzema, Abraham

Publication type:

journal article